Covered recipient · General Payments record
JOSEPH DELUCA
General Payments · PY2018–2024
$4,153.06
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,216.77 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $992.14 | 9 |
| GLAUKOS CORPORATION | $142.22 | 2 |
| Tarsus Pharmaceuticals, Inc. | $36.00 | 2 |
| Ocular Therapeutix, Inc. | $28.33 | 2 |
| Sight Sciences, Inc. | $18.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alcon Vision LLC | $115.85 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110564541 | CMS |
| Alcon Vision LLC | $109.95 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110564539 | CMS |
| Alcon Vision LLC | $37.74 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110564533 | CMS |
| Alcon Vision LLC | $95.36 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110564535 | CMS |
| Alcon Vision LLC | $100.90 | 01/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110564537 | CMS |
| Alcon Vision LLC | $20.45 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110564531 | CMS |
| Alcon Vision LLC | $145.08 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110564545 | CMS |
| Alcon Vision LLC | $241.80 | 04/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110564547 | CMS |
| Alcon Vision LLC | $125.01 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110564543 | CMS |
| Glaukos Corporation | $36.27 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151993677 | CMS |
| Glaukos Corporation | $105.95 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151993679 | CMS |
| Ocular Therapeutix, Inc. | $13.67 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148200173 | CMS |
| Ocular Therapeutix, Inc. | $14.66 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148200171 | CMS |
| Sight Sciences, Inc. | $18.08 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151927465 | CMS |
| Tarsus Pharmaceuticals, Inc. | $17.00 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139092065 | CMS |
| Tarsus Pharmaceuticals, Inc. | $19.00 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139092067 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.